Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
SCYNEXIS, Inc. - Common Stock
(NQ:
SCYX
)
0.7998
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about SCYNEXIS, Inc. - Common Stock
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
February 23, 2022
Gainers SCYNEXIS (NASDAQ:SCYX) shares inc...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
February 23, 2022
On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
February 11, 2022
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock rose 29.0% to $1.38 during Friday's pre-market session. The company's market cap stands at $11.4 million. Innoviva...
Via
Benzinga
Scynexis Aces Ibrexafungerp Late-Stage Study To Prevent Vaginal Yeast Infections
↗
February 10, 2022
Scynexis Inc (NASDAQ: SCYX) has announced results from its Phase 3 CANDLE study of oral ibrexafungerp to prevent recurrent vulvovaginal candidiasis (rVVC), also known as vaginal yeast infection.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
November 19, 2021
Gainers SCYNEXIS (NASDAQ:SCYX) stock rose 15.69% to $7.15 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 1.2 million shares...
Via
Benzinga
52 Biggest Movers From Friday
↗
November 22, 2021
Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares surged 90.2% to close at $9.89 on Friday. Greenland Technologies highlighted the launch of second...
Via
Benzinga
33 Stocks Moving In Friday's Mid-Day Session
↗
November 19, 2021
Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares jumped 75.4% to $9.17. Greenland Technologies highlighted the launch of second electric industrial...
Via
Benzinga
70 Biggest Movers From Yesterday
↗
November 16, 2021
Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
November 15, 2021
Gainers Tricida (NASDAQ:TCDA) shares rose...
Via
Benzinga
Scynexis Presents Interim Ibrexafungerp Data In Hospital-Based Fungal Infections
↗
September 29, 2021
Scynexis Inc (NASDAQ: SCYX) announced an oral presentation of interim data analyses from its ongoing Phase 3 FURI study of oral ibrexafungerp in severe hospital-...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates
↗
July 01, 2021
June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive...
Via
Benzinga
Scynexis' Brexafemme For Vaginal Yeast Infections Secures 10 Years Regulatory Exclusivity
↗
June 09, 2021
The FDA has granted five years of exclusivity extension under the Generating Antibiotic Incentives Now (GAIN) Act to Scynexis Inc's (NASDAQ: SCYX)...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
June 02, 2021
Gainers Constellation (NASDAQ:CNST) shares rose 67.19% to $33.84 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 19.5...
Via
Benzinga
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
↗
June 07, 2021
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
↗
June 02, 2021
Gainers BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously...
Via
Benzinga
66 Biggest Movers From Yesterday
↗
June 03, 2021
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) surged 95.2% to close at $62.55 on Wednesday amid renewed interest from retail investors. AMC Entertainment shares jumped...
Via
Benzinga
Scynexis Scores FDA Nod For Brexafemme, Oral Treatment For Vaginal Yeast Infection
↗
June 02, 2021
The FDA has approved Scynexis Inc's (NASDAQ: SCYX) Brexafemme (ibrexafungerp tablets) for oral use in patients with vulvovaginal candidiasis (VVC), also known...
Via
Benzinga
The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements
↗
June 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
June 02, 2021
Gainers Constellation (NASDAQ:CNST) shares moved upwards by 66.55% to $33.71 during Wednesday's pre-market session. The market value of their outstanding shares is at...
Via
Benzinga
22 Stocks Moving in Wednesday's Pre-Market Session
↗
June 02, 2021
Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) rose 37.2% to $1.99 in pre-market trading after the company said it received orphan drug designation from the European...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
↗
June 01, 2021
The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive...
Via
Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
↗
June 01, 2021
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) rose 43.5% to $11.21 in pre-market trading. Vertex Energy, shares jumped around 96% on Friday on continued momentum after the company...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
May 24, 2021
Gainers Strongbridge Biopharma (NASDAQ:SBBP) stock moved upwards by 14.1% to $2.75 during Monday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
↗
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Scynexis Raises $60M Via Term Loan Ahead Of Expected Approval Of Vaginal Yeast Infection Treatment
↗
May 14, 2021
Scynexis Inc (NASDAQ: SCYX) is taking out a loan to ensure it can hit the ground running for a potential commercial launch of ibrexafungerp for vaginal yeast infections...
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today